Stocks · Healthcare · Medical - Care Facilities
AMN Healthcare Services, Inc. AMN
$36.63 +2.15% Close, Oct 2, 2026 · NYSE · Market cap $1.42B
High qualityStrong trendInexpensive vs sector
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to 4.7% from -10.5% a year earlier.
- Over the past year the stock returned +83.4%, ahead of the S&P 500 by 68.4 percentage points.
- The stock is in an uptrend: above its 200-day average for 119 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 29%
- FCF growth (TTM, YoY)Top 21%
- Revenue growth, 3-year CAGRBottom 8%
- Revenue growth accelerationTop 20%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 21%
- Gross marginBottom 17%
- Operating marginTop 35%
- Cash conversion (OCF / net income)Top 10%
- Accruals (lower is better)Top 22%
- Net debt / EBITDA (lower is better)Top 50%
- Interest coverTop 27%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 5%
- Free-cash-flow yieldTop 2%
- EBITDA / enterprise valueTop 3%
- Sales / enterprise valueTop 4%
- P/E vs own 5-year history (lower is better)Bottom 34%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 27%
- 6-month returnTop 8%
- 1-year return vs S&P 500Top 18%
- Distance from 52-week highTop 1%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 4%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyBottom 24%
- Upside to consensus price targetBottom 11%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 44%
- Maximum drawdown, 3 yearsBottom 28%
- Beta vs S&P 500 (lower is better)Top 31%
- Net debt / EBITDA (lower is better)Top 50%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 19.9% | 24.0% | ↑ |
| Gross margin | 29.8% | 27.8% | ↓ |
| Operating margin | -10.5% | 4.7% | ↑ |
| FCF margin | 9.2% | 12.8% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 24.0% | 19.9% | ↑ | Top 29% |
| Gross margin | 27.8% | 29.8% | ↓ | Bottom 17% |
| Operating margin | 4.7% | -10.5% | ↑ | Top 35% |
| Net margin | 3.1% | -10.8% | ↑ | — |
| Free-cash-flow margin | 12.8% | 9.2% | ↑ | — |
| Return on invested capital | 6.4% | — | Top 21% | |
| Revenue growth, 3-year CAGR | -19.5% | — | Bottom 8% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -15.5%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.9%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -40.4 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 1.20×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 4.5×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.35%
- Shareholder yield
- 0.35%
- Share count change, 1 year
- +3.4%
- Share count change, 3-year CAGR
- +0.3%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 7, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +100.0%
- Average 2-day reaction, last 8
- +0.1%
- Positive 20 days after report
- 6 of 8
Analysts
- Consensus price target
- $37.00
- Target vs current price
- +1.0%
- Analysts with a rating
- 17
- Share rating Buy or Strong Buy
- 59%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +307.8% | -6.1% | -1.1% | +1.8% | — |
| May 7, 2026 | +31.3% | +7.1% | +47.2% | +46.0% | +57.4% |
| Feb 19, 2026 | +0.0% | +1.2% | +17.2% | +5.0% | +77.4% |
| Nov 6, 2025 | +105.3% | -10.7% | -19.6% | -19.7% | -0.4% |
| Aug 7, 2025 | +76.5% | -1.7% | +8.2% | +17.5% | +12.7% |
| May 8, 2025 | +136.8% | +3.7% | +11.0% | +2.4% | -11.1% |
| Feb 20, 2025 | +44.2% | +8.4% | +8.9% | +3.1% | -6.1% |
| Nov 7, 2024 | +5.2% | -0.7% | -40.3% | -35.1% | -35.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | $0.77 | $0.19 | +307.8% | $673.2M |
| May 7, 2026 | $2.10 | $1.60 | +31.3% | $1.38B |
| Feb 19, 2026 | $0.22 | $0.22 | +0.0% | $748.2M |
| Nov 6, 2025 | $0.39 | $0.19 | +105.3% | $634.5M |
| Aug 7, 2025 | $0.30 | $0.17 | +76.5% | $658.2M |
| May 8, 2025 | $0.45 | $0.19 | +136.8% | $689.5M |
| Feb 20, 2025 | $0.75 | $0.52 | +44.2% | $734.7M |
| Nov 7, 2024 | $0.61 | $0.58 | +5.2% | $687.5M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 13.7× | 12.0× | 60th | Top 5% |
| P/E (forward) | 11.1× | — | — | — |
| EV / EBITDA | 5.3× | — | — | Top 3% |
| EV / Sales | 0.53× | — | — | Top 4% |
| Free-cash-flow yield | 30.91% | — | — | Top 2% |
| Earnings yield | 7.32% | — | — | Top 5% |
P/E over the past five years
Range 9.6× – 29.6× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 7
- Days above the 200-day average
- 119
- 50-day average slope (20 days)
- +1.4%
- 200-day average slope (20 days)
- +7.5%
- Distance from 50-day average
- +7.0%
- Distance from 200-day average
- +41.4%
- RSI (14)
- 65.4
- Relative volume
- 1.42×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 52.8%
- Volatility vs own 5-year history
- 64th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.79
- Correlation with S&P 500
- 0.19
- Current drawdown from 1-year high
- +0.0%
- Maximum drawdown, 3 years
- -82.7%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 1, 2022 | Jan 5, 2026 | -88.1% | 795 days | Not yet recovered |
| Dec 27, 2021 | May 13, 2022 | -31.5% | 96 days | 116 days (Oct 28, 2022) |
| Oct 12, 2021 | Oct 20, 2021 | -23.1% | 6 days | 46 days (Dec 27, 2021) |
| Nov 3, 2020 | Nov 20, 2020 | -14.0% | 13 days | 13 days (Dec 10, 2020) |
| Feb 19, 2021 | Mar 4, 2021 | -11.6% | 9 days | 35 days (Apr 23, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.42B
- P/E (TTM)
- 13.7
- EPS, diluted (TTM)
- $2.68
- Revenue (TTM)
- $3.43B
- 52-week range
- $14.97 – $37.22
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $3.98B | $5.24B | $3.79B | $2.98B | $2.73B |
| Gross profit | $1.31B | $1.72B | $1.25B | $919.4M | $774.1M |
| Operating income | $478.0M | $647.1M | $338.4M | -$102.7M | $33.2M |
| Net income | $327.4M | $444.1M | $210.7M | -$147.0M | -$95.7M |
| EPS (diluted) | $6.81 | $9.90 | $5.36 | -$3.85 | -$2.48 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $687.5M | $734.7M | $689.5M | $658.2M | $634.5M | $748.2M | $1.38B | $673.2M |
| Net income | $7.0M | -$187.5M | -$1.1M | -$116.2M | $29.3M | -$7.7M | $62.2M | $21.2M |
| EPS (diluted) | $0.18 | -$4.90 | -$0.03 | -$3.02 | $0.76 | -$0.20 | $1.59 | $0.53 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $305.4M | $653.7M | $372.2M | $320.4M | $269.5M |
| Capital expenditure | -$53.7M | -$80.9M | -$103.7M | -$80.9M | -$35.6M |
| Free cash flow | $251.7M | $572.8M | $268.5M | $239.5M | $233.8M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$2.7M | -$576.8M | -$424.7M | $0 | -$2.1M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $361.8M
- Total assets
- $2.36B
- Total liabilities
- $1.62B
- Total debt
- $775.8M
- Net debt
- $414.0M
- Shareholders’ equity
- $741.3M
As of Jun 30, 2026 (filed Aug 7, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Sep 29, 2011 | $0.30 | — |
| Jul 26, 2011 | $0.30 | Aug 16, 2011 |
| Apr 26, 2011 | $0.30 | May 17, 2011 |
| Jan 25, 2011 | $0.30 | Feb 15, 2011 |
| Nov 8, 2010 | $3.00 | Nov 30, 2010 |
| Oct 26, 2010 | $0.30 | Nov 16, 2010 |
| Jul 20, 2010 | $0.30 | Aug 17, 2010 |
| Apr 20, 2010 | $0.30 | May 18, 2010 |
Short interest
- Shares sold short
- 3,488,132
- Days to cover
- 5.91
- Change vs previous report
- +2.0%
FINRA short interest, settlement date Sep 15, 2026.